ArticleFrontiers in immunology2025

Combination of drug-eluting bead transarterial chemoembolization and PD-1 inhibitor for treatment of unresectable head and neck squamous cell carcinoma: an initial, short-term clinical experience in a single-center retrospective cohort study.

Bo Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.